Inactive Instrument

News Sartorius Aktiengesellschaft Other OTC

Equities

SARTORIUS VORZUEGE : UBS remains Neutral	20/06	ZD
Sartorius stabilizes after previous day's price slide	20/06	DP
Sartorius on the downswing again - low since 2020 is approaching	19/06	DP
Sartorius Opens New Center of Excellence for Bioanalytics in Ann Arbor	06/06	CI
Sartorius Launches $100 Million US Flagship Site	06/06	MT
Sartorius : opens new Center of Excellence for bioanalytics in Ann Arbor	06/06	PU
SARTORIUS VORZUEGE : Jefferies reaffirms its Neutral rating	28/05	ZD
Ailing hospitals slow down German medical technology sector	23/05	DP
JPMorgan lowers target for Sartorius to 330 euros - 'Overweight'	22/05	DP
SARTORIUS VORZUEGE : Buy rating from JP Morgan	22/05	ZD
SARTORIUS VORZUEGE : Jefferies sticks Neutral	17/05	ZD
SARTORIUS VORZUEGE : Deutsche Bank sticks Neutral	17/05	ZD
SARTORIUS VORZUEGE : Warburg Research sticks Neutral	17/05	ZD
SARTORIUS VORZUEGE : Barclays remains Neutral	17/05	ZD
German Shares Close Lower as ECB Keeps 'Fragile' Outlook	16/05	MT
Sartorius Partners with Nvidia on Drug Discovery, Manufacturing Using AI	16/05	MT
Sartorius sinks again towards year low	16/05	DP
SARTORIUS VORZUEGE : UBS remains Neutral	16/05	ZD
Sartorius to advance drug discovery and manufacturing with AI in collaboration with NVIDIA	16/05	EQ
Transcript : Sartorius Stedim Biotech S.A., Sartorius Aktiengesellschaft - Analyst/Investor Day	16/05

No results for this search

SARTORIUS : Target cut by -6.1%

April 30, 2024 at 10:05 pm IST